Therapies that use stem cells to repair or replace damaged cells in the brains of patients with Parkinson’s disease have been ...

2 describe the outcome of a phase I clinical trial in which 12 people in the United States and Canada were treated with dopaminergic progenitor cells derived from a human embryonic stem-cell line.

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...

A team of CiRA researchers has uncovered the crucial role of EIF3D—a protein translational regulator—in primed pluripotency.

Applied StemCell solidifies their commitment to cell therapy development with a DMF submitted to the US FDA for the ActiCells™ GMP hiPSC line.

Medicare covers FDA-approved stem cell therapies for bleeding disorders and certain cancers, though out-of-pocket costs can still be high. Medicare Advantage or supplement plans may help with the ...

11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for ... Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout Punch ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Home > Pressemitteilung: Detection of Neural Stem Cells ... < pNSCs distribute along the bronchial of mouse postnatal (image) and adult lung. These cells are spec ... MPI for Molecular Biomedicine / ...

In conclusion, our studies indicate that both male germ line stem cells and the supporting ... of assisted reproductive techniques, and testis cell transplantation should allow additional progress ...

Roche (RHHBY) announced that the European Commission, EC, has approved Columvi in combination with gemcitabine and oxaliplatin for the ...